Business Summary:
Seeking partnerships of a pharmaceutical company to advance clinical testing, or Sale of an antiviral drug for COVID-19: the company is currently developing potential antiviral compounds for the primary drug candidate, SBT-0704. The drug is designed both for prophylactic and antiviral use and is intended to be administered via a single-use inhaler. SBT-0704 brings the power to fight COVID directly to the user, without visiting a clinic for administration and intended for use in any setting. The company has decided to review offers from interested parties to acquire the relevant intellectual property and develop it either on its own or via a strategic partnership. 10457
|
|
